5 statements from the Australian Health Protection Principal Committee about COVID-19. On this page: AHPPC notes that there is currently very limited evidence to support the use of medications for the treatment of COVID-19.
Several medications have been proposed as likely candidates to treat COVID-19. There are currently clinical trials both within Australia, and internationally, to test their efficacy and safety.
Broadly, the medication classes that have been suggested may help manage those with COVID-19 include: Some of these medications are marketed within Australia for indications other than COVID-19, and have known pharmacokinetics, pharmacodynamics and side effect profiles.